The Role of Circulating Tumor DNA in Evaluating Minimal Residual Disease in Luminal Gastrointestinal Malignancies

Abstract: The analysis of circulating tumor DNA (ctDNA) has multiple uses in oncology. In the past few years, studies with varying designs, methods, and quality have […]

Circulating Tumor DNA as a Marker of Minimal Residual Disease in Colorectal Cancer

H&O How common is recurrence after surgery for nonmetastatic colon cancer? SK Most patients with stage II or III colon cancer have a risk for […]

Measurement of Circulating Tumor DNA to Guide Management of Patients with Lymphoma

Abstract In recent years, advances have been made in methods to assess response to therapy in lymphoma. Ideally, response assessment tools should be highly sensitive […]